This HTML5 document contains 110 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
n12http://dx.doi.org/10.1016/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n6http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q45129897
rdf:type
wikibase:Item
schema:description
2010年学术文章 artigo científico article científic מאמר מדעי article scientific bài báo khoa học artikull shkencor wetenschappelijk artikel 2010 nî lūn-bûn 2010年學術文章 2010年学术文章 artículo científico publicado en 2010 article scientifique 2010年学术文章 articol științific scientific article published on 8 October 2010 artykuł naukowy artigo científico scienca artikolo научни чланак scientific article published on 8 October 2010 ৮ অক্টোবর ২০১০-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ vedecký článok artigo científico 2010년 논문 2010 թվականի հոկտեմբերի 8-ին հրատարակված գիտական հոդված наукова стаття, опублікована в жовтні 2010 tudományos cikk 2010年学术文章 مقالة علمية نشرت في 8 أكتوبر 2010 επιστημονικό άρθρο artículu científicu научная статья naučni članak 2010年學術文章 2010年学术文章 2010年学术文章 vitskapeleg artikkel teaduslik artikkel 2010年學術文章 บทความทางวิทยาศาสตร์ 2010年學術文章 мақолаи илмӣ artikulong pang-agham 2010年の論文 wissenschaftlicher Artikel научни чланак სამეცნიერო სტატია artikel ilmiah videnskabelig artikel articolo scientifico vitenskapelig artikkel tieteellinen artikkeli 2010年學術文章 научна статия vědecký článek vetenskaplig artikel bilimsel makale scientific article published on 8 October 2010
p:P577
wds:Q45129897-DB6E0565-5CFF-46C1-8233-E4CA192B1909
wdt:P577
2010-10-08T00:00:00Z
p:P407
wds:Q45129897-AAB45EAD-04A2-48F8-8187-A57FE6967084
wdt:P407
wd:Q1860
p:P2093
wds:Q45129897-3CFC42D1-2B19-4D2C-A57B-4B3D50B44F5A wds:Q45129897-504BDA7A-F381-4CB9-A8E6-0C27701FCD04 wds:Q45129897-71326666-2D24-4125-9CCA-7E493A5BC328 wds:Q45129897-916FFBDF-299C-493B-A325-71E9DD184C6D wds:Q45129897-2D6F6006-4320-44FF-A46D-DABBC5C2E1D7 wds:Q45129897-0453D6A3-2658-46E8-A972-304BBB39496D wds:Q45129897-3AFBEFFC-F0DA-431B-AEBE-DA24BD1148F3
wdt:P2093
James Signorovitch Parvez M Mulani Karthik Ramakrishnan Kristian Reich Shiraz R Gupta Yanjun Bao Andrew P Yu
rdfs:label
Benefit-risk analysis of adalimumab versus methotrexate and placebo in the treatment of moderate to severe psoriasis: comparison of adverse event-free response days in the CHAMPION trial Benefit-risk analysis of adalimumab versus methotrexate and placebo in the treatment of moderate to severe psoriasis: comparison of adverse event-free response days in the CHAMPION trial
skos:prefLabel
Benefit-risk analysis of adalimumab versus methotrexate and placebo in the treatment of moderate to severe psoriasis: comparison of adverse event-free response days in the CHAMPION trial Benefit-risk analysis of adalimumab versus methotrexate and placebo in the treatment of moderate to severe psoriasis: comparison of adverse event-free response days in the CHAMPION trial
schema:name
Benefit-risk analysis of adalimumab versus methotrexate and placebo in the treatment of moderate to severe psoriasis: comparison of adverse event-free response days in the CHAMPION trial Benefit-risk analysis of adalimumab versus methotrexate and placebo in the treatment of moderate to severe psoriasis: comparison of adverse event-free response days in the CHAMPION trial
p:P50
wds:Q45129897-E4589434-38EE-4A70-A978-499DD4E9AC1A
wdt:P50
wd:Q67190782
p:P1476
wds:Q45129897-335EE5E9-BC7C-4BBE-8E27-7B987AEEE72A
wdt:P1476
Benefit-risk analysis of adalimumab versus methotrexate and placebo in the treatment of moderate to severe psoriasis: comparison of adverse event-free response days in the CHAMPION trial
p:P304
wds:Q45129897-CB474A8B-4D86-4FC0-9677-93F4DFE322C9
wdt:P304
1011-1018
p:P31
wds:Q45129897-67A732E1-227B-4F85-9D75-A61C73E35239
wdt:P31
wd:Q13442814
p:P921
wds:Q45129897-35BFDB27-9010-4940-ABF2-FDB27392235E wds:Q45129897-BC04264A-1400-4DAA-9CF3-65A26F78137A wds:Q45129897-C52090CE-971B-49B7-A164-4D16B42EFE54
wdt:P921
wd:Q11679892 wd:Q348260 wd:Q422232
p:P698
wds:Q45129897-3B14F8F4-8C03-47BA-B1BA-0E99BD8191E9
wdtn:P698
n6:20933301
wdt:P698
20933301
p:P1433
wds:Q45129897-93891BF3-F39C-4B18-B7E0-3E1FCA99FBBB
wdt:P1433
wd:Q15757046
p:P433
wds:Q45129897-5544E632-D746-4D1B-BA66-F55E93BD64A3
p:P478
wds:Q45129897-C92E6595-4463-4B0F-9247-7FFE347C7231
wdt:P433
6
wdt:P478
63
p:P356
wds:Q45129897-13E445B7-0AA0-43E5-B60D-CCF8EBECDD9F
wdtn:P356
n12:J.JAAD.2009.12.029
wdt:P356
10.1016/J.JAAD.2009.12.029